EssilorLuxottica acquires the Canadian med-tech start-up Cellview

Core Insights - EssilorLuxottica has acquired Cellview Imaging Inc, a Canadian med-tech start-up specializing in innovative retinal imaging technology, to enhance its portfolio in vision care [1][2] Group 1: Acquisition Details - The acquisition aims to elevate industry standards and improve the quality of vision care through advanced diagnostic tools [1] - Cellview's proprietary ultra-widefield retinal camera captures larger images, enabling better diagnosis of retinal pathologies [2] Group 2: Company Background - Cellview is based in Toronto and is known for its strong internal R&D capabilities, producing FDA and CE approved diagnostic imaging instruments [2] - The company's products are currently distributed in North America and are set to expand into Europe [2] Group 3: Strategic Goals - EssilorLuxottica's leadership expressed enthusiasm about integrating Cellview's expertise to accelerate their vision health strategy [3] - The integration is expected to provide a comprehensive portfolio of innovative technologies to the ophthalmic care community, addressing the growing need for early diagnosis of retinal conditions [3]